Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00398_DB00958 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00398_DB00958 label "DDI between Sorafenib and Carboplatin - Sorafenib may enhance the adverse/toxic effect of carboplatin. Concurrent use of sorafenib with carboplatin and placlitaxel in patients with squamous cell lung cancer is contraindicated. The use of this combination in other settings is not specifically contraindicated, but any such use should be approached with added caution. [drugbank_resource:DB00398_DB00958]" assertion.
- drugbank_resource:DB00398_DB00958 identifier "drugbank_resource:DB00398_DB00958" assertion.
- drugbank_resource:DB00398_DB00958 title "DDI between Sorafenib and Carboplatin - Sorafenib may enhance the adverse/toxic effect of carboplatin. Concurrent use of sorafenib with carboplatin and placlitaxel in patients with squamous cell lung cancer is contraindicated. The use of this combination in other settings is not specifically contraindicated, but any such use should be approached with added caution." assertion.
- drugbank:DB00958 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00398_DB00958 assertion.
- drugbank:DB00398 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00398_DB00958 assertion.